| [1] |
Yuan Jian, Huang Yanhua.
Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer
[J]. Journal of International Oncology, 2024, 51(6): 338-343.
|
| [2] |
Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.
Study on the clinical relationship between inflammatory burden index and gastric cancer
[J]. Journal of International Oncology, 2024, 51(5): 274-279.
|
| [3] |
Wang Kun, Zhou Zhongxin, Zang Qiwei.
Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection
[J]. Journal of International Oncology, 2024, 51(4): 198-203.
|
| [4] |
Xie Shuping, Sun Yahong, Wang Chao.
Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 157-165.
|
| [5] |
Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.
Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 175-180.
|
| [6] |
Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.
Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(2): 89-94.
|
| [7] |
Shao Huifang, Wang Xuehong, Lu Yongfu.
Mechanism of action and clinical significance of CST1 in the progression of gastric cancer
[J]. Journal of International Oncology, 2023, 50(8): 489-492.
|
| [8] |
Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu.
Level of serum FABP1 and its relationship with Helicobacter pylori infection in patients with gastric cancer
[J]. Journal of International Oncology, 2023, 50(6): 336-341.
|
| [9] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
| [10] |
Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen.
Correlation between blood lipid level and gastric cancer
[J]. Journal of International Oncology, 2023, 50(3): 183-185.
|
| [11] |
Fan Shanlin, Wang Pinxiu, Kong Fei, Zhou Yujie, Yuan Wenzhen.
Progress in the study of predictors of tumor regression grade after neoadjuvant chemotherapy for gastric cancer
[J]. Journal of International Oncology, 2023, 50(2): 112-116.
|
| [12] |
Yang Jun, Li Rong, Zeng Jianchang.
Clinical efficacy of Compound Kushen Injection combined with SOX regimen in the treatment of elderly patients with advanced gastric cancer
[J]. Journal of International Oncology, 2023, 50(2): 82-86.
|
| [13] |
Deng Lili, Duan Xingyu, Li Baozhong.
Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(12): 751-757.
|
| [14] |
Li Jiayi, Wang Yue, Shang Lanlan, Xu Xing, Zhao Yan.
Practice and prospect of artificial intelligence in diagnosis and treatment of gastric cancer
[J]. Journal of International Oncology, 2023, 50(11): 677-682.
|
| [15] |
Yu Xiaopeng, Feng Qingqing, Zhao Wenfei, Zhao Wenwen, Wei Hongmei.
Application of targeted therapy combined with immune checkpoint inhibitors in the treatment of HER2 positive advanced gastric cancer
[J]. Journal of International Oncology, 2023, 50(10): 631-635.
|
